Authors

• Takeshi Terashima (ORCID: https://orcid.org/0000-0002-4353-7647)
• Hideki Kobara (ORCID: https://orcid.org/0000-0002-8508-827X)
• Y. Kawamura
• Norikazu Tanabe (ORCID: https://orcid.org/0009-0005-9502-8886)
• Kenji Yamaoka (ORCID: https://orcid.org/0000-0002-8896-3455)
• Joji Tani (ORCID: https://orcid.org/0000-0001-8801-2505)
• Taro Takami
• Takahiro Yamasaki (ORCID: https://orcid.org/0000-0002-9793-0399)
• Norio Akuta (ORCID: https://orcid.org/0000-0001-5386-9672)
• Tetsuji Takayama (ORCID: https://orcid.org/0000-0002-0175-1573)
• Tetsu Tomonari
• Tomokazu Kawaoka (ORCID: https://orcid.org/0000-0002-1887-1096)
• Taro Yamashita (ORCID: https://orcid.org/0000-0002-3383-9131)
• Issei Saeki (ORCID: https://orcid.org/0000-0001-5885-5042)
• Shiro Oka

Institutions

• Yamaguchi University (JP)
• Kagawa University (JP)
• Kanazawa University Hospital (JP)
• Yamaguchi University Hospital (JP)
• Hiroshima University Hospital (JP)
• Toranomon Hospital (JP)
• Tokushima University (JP)

Publication Details

Journal

Anticancer Research

Published

2025-03-01

DOI

https://doi.org/10.21873/anticanres.17499

Citations

2

Primary Topic

Cholangiocarcinoma and Gallbladder Cancer Studies

Type

article

Field-Weighted Citation Impact

4.01